LordsMed expands global footprint with launch of export division for diagnostic supplies

Mumbai: LordsMed, the global healthcare division of Lord’s Mark Industries has announced the commencement of export venture of diagnostic supplies to Nepal. The company aims to establish itself as a leading global player in In-Vitro Diagnostics (IVD) manufacturing and export.

With a strong commitment to delivering quality IVD solutions at a reduced cost, LordsMed has successfully built a vast network of over 300 distributor channels across India. The manufacturing facilities located in the outskirts of Mumbai, currently has the capacity to facilitate an impressive 1.7 crore diagnostic tests per month, covering a wide range of specialties including biochemistry, haematology, serology, rapid tests, and urine strip tests.

Commenting on the launch, Manav Teli, Executive Director, Lord’s Mark Industries said “We are thrilled to announce the launch of our Export Division and our first venture into Nepal. Our goal has always been to emerge as a global leader in IVD manufacturing and export, providing top-quality solutions at an affordable cost. With our advanced manufacturing facilities and extensive distributor network, we are now expanding our reach to neighbouring countries. This marks a significant milestone in our journey towards meeting the healthcare needs of a wider population. We are also excited to explore OEM opportunities and further scale up our manufacturing capacity, ensuring accessible diagnostics for all.”

As Lord’s Mark Industries continues to strengthen its presence in the Indian market, the company is now strategically focusing on supplying neighbouring countries with its high-quality IVD products. The conglomerate currently has five companies: LordsMed, Lord’s Mark Biotech, Lord’s Mark Microbiotech, Brahamastra Defense Techno Products Limited, Lord’s Mark Insurance Broking Limited, and Lords Automative Private Limited, with other verticals in renewable energy products and paper.